(Q45251697)

11 December 2017

title

Cholesterol, racial variation and targeted medicines (English)

1 reference

11 December 2017

1

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 December 2017

number of pages

2

1 reference

based on heuristic

inferred from page(s)

published in

Nature Medicine

1 reference

11 December 2017

volume

11

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

122-123

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0205-122

11 December 2017

exact match

0 references

cites work

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

21 January 2018

The mystery of PCSK9.

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

How does mutant proprotein convertase neural apoptosis-regulated convertase 1 induce autosomal dominant hypercholesterolemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Genetic variants in PCSK9 affect the cholesterol level in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0205-122

21 January 2018

Identifiers

DOI

10.1038/NM0205-122

1 reference

Dimensions Publication ID

11 December 2017

1034600378

0 references

1 reference